- Home
- BRTX vs STRR Comparison
BRTX vs STRR Comparison
Compare BRTX & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- STRR
- Stock Information
- Founded
- BRTX 1997
- STRR 1985
- Country
- BRTX United States
- STRR United States
- Employees
- BRTX N/A
- STRR N/A
- Industry
- BRTX Managed Health Care
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BRTX Health Care
- STRR Health Care
- Exchange
- BRTX Nasdaq
- STRR Nasdaq
- Market Cap
- BRTX 11.3M
- STRR 13.3M
- IPO Year
- BRTX N/A
- STRR N/A
- Fundamental
- Price
- BRTX $1.46
- STRR $3.17
- Analyst Decision
- BRTX Strong Buy
- STRR
- Analyst Count
- BRTX 1
- STRR 0
- Target Price
- BRTX $18.00
- STRR N/A
- AVG Volume (30 Days)
- BRTX 34.6K
- STRR 11.2K
- Earning Date
- BRTX 11-12-2024
- STRR 11-19-2024
- Dividend Yield
- BRTX N/A
- STRR N/A
- EPS Growth
- BRTX N/A
- STRR N/A
- EPS
- BRTX N/A
- STRR N/A
- Revenue
- BRTX $377,000.00
- STRR $47,147,000.00
- Revenue This Year
- BRTX $598.90
- STRR $19.97
- Revenue Next Year
- BRTX $162.81
- STRR $41.50
- P/E Ratio
- BRTX N/A
- STRR N/A
- Revenue Growth
- BRTX 189.55
- STRR N/A
- 52 Week Low
- BRTX $1.03
- STRR $3.04
- 52 Week High
- BRTX $3.67
- STRR $6.55
- Technical
- Relative Strength Index (RSI)
- BRTX 39.02
- STRR 30.65
- Support Level
- BRTX $1.44
- STRR $3.04
- Resistance Level
- BRTX $1.78
- STRR $3.83
- Average True Range (ATR)
- BRTX 0.16
- STRR 0.23
- MACD
- BRTX -0.01
- STRR -0.04
- Stochastic Oscillator
- BRTX 24.93
- STRR 16.44
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.